News
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
Data from a phase 3 study indicated the microbiota-based live biotherapeutic RBL was safe and efficacious for recurrent CDI prevention in immunocompromised patients.
For patients with immune-mediated inflammatory diseases, CVD mortality decreased from 1999 to 2020, but sex disparities persist.
According to a recent study, glucagon-like peptide-1 receptor agonists are associated with a reduction in alcohol intake.
Children with DKA had an increased likelihood of positive celiac serologies, and those with positive tTG-IgA had higher HbA1c concentrations.
The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.
Obesity did not significantly impact colonic endoscopic submucosal dissection results, but overtubes were used more for right-sided lesion dissection.
Among Medicare beneficiaries with IBD, Black, Asian, and Hispanic patients have lower health care utilization patterns than White patients.
The FDA has approved Selarsdi (ustekinumab-aken) as interchangeable to the reference product Stelara (ustekinumab).
Trump signed an executive order instructing the HHS to align Medicare payments for drugs with the lowest prices paid by other nations.
Eating a healthy diet is linked to girls having their first menstrual period at an older age than those who consume a less healthy diet.
The nominee and her brother have criticized processed foods and the pharmaceutical industry, linking poor diets to health issues like obesity, depression and Alzheimer’s. HealthDay News — President ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results